Addus HomeCare Corp
At today's price, Addus HomeCare Corp (ADUS) is priced for +5.4% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
At $94.32 the market pays about 14x company-wide operating income for Addus, which works out to an embedded assumption of roughly 1.5% annual operating-profit growth for five years. That is a low bar for a business that has been compounding revenue in the high teens to low twenties through acquisitions. The mix is overwhelmingly personal care (77%), with hospice at 18% and home health at 5%. Personal care grew 8.8% to $281.1M in Q1 2026, and the segment serves a mostly dual-eligible population,
Is ADUS overvalued? See what's priced in →
287 institutional managers reported holding ADUS in 13F filings for the quarter ended 2026-03-31. 36 opened new positions that quarter. Held by BlackRock, Vanguard Group, Dimensional Fund Advisors, among others. On the short side, 927k shares were sold short as of the 2026-06-15 count, about 5% of shares outstanding (4.5 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
ADUS's share count grew 15.6% over the past five years. It pays no dividend.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at ADUS over the trailing three years. Absence is a fact about the company, not a signal. 18 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
ADUS's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-02 | +4.3% | -13.4% |
| 2023-11-01 | -3.7% | +12.1% |
| 2024-02-28 | +3.4% | +7.1% |
| 2024-05-08 | +6.5% | +10.9% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
ADUS's latest 8-K filings: 2026-06-10 (items 5.07); 2026-05-04 (items 2.02, 7.01, 9.01); 2026-02-23 (items 2.02, 7.01, 9.01); 2025-11-03 (items 2.02, 7.01, 9.01); 2025-08-07 (items 5.02, 7.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.